In an 18‑year‑old with acute hematochezia, abdominal cramping, recent constipation, difficulty gaining weight and no family history of gastrointestinal disease, what blood tests should be ordered to rule out Crohn’s disease and evaluate for irritable bowel syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Tests for Evaluating Crohn's Disease and IBS in an 18-Year-Old with Hematochezia

In this 18-year-old presenting with acute hematochezia, abdominal cramping, constipation, and difficulty gaining weight, you should order: complete blood count (CBC), fecal calprotectin, IgA tissue transglutaminase with total IgA level, stool testing for Giardia, and fecal occult blood test—but the presence of hematochezia and weight loss are alarm features that mandate colonoscopy regardless of laboratory results. 1, 2, 3

Critical Context: This is NOT Typical IBS

The presence of hematochezia and difficulty gaining weight are absolute alarm features that exclude a simple functional IBS diagnosis and require endoscopic evaluation. 1, 3 While blood tests are important, they serve primarily to characterize the disease severity and exclude other conditions—colonoscopy with biopsies is mandatory in this clinical scenario. 1, 2

Essential Blood Tests to Order

Mandatory Initial Panel

  • Complete Blood Count (CBC) – Screen for anemia (particularly iron deficiency from chronic blood loss) and inflammatory changes (elevated white blood cell count suggesting IBD). 1, 2, 3 Anemia has very high specificity for organic disease even though sensitivity is limited. 4

  • Fecal Calprotectin – This is the single best non-invasive test to distinguish inflammatory bowel disease from IBS, with 100% sensitivity and 97% specificity when using a cutoff of >50 mg/g. 5, 6 In patients under age 45 with diarrhea or hematochezia, this test is particularly valuable. 1, 2 Fecal calprotectin correlates directly with intestinal inflammation and neutrophil activity. 7, 6

  • IgA Tissue Transglutaminase (IgA-tTG) with Total IgA Level – Celiac disease must be excluded in all patients with chronic GI symptoms, as it has >90% sensitivity and can present with IBS-like symptoms. 1, 2 If IgA deficiency is detected, switch to IgG-based testing (IgG-deamidated gliadin peptide or IgG-tTG). 2

  • Stool Testing for Giardia Antigen – Giardia is a common parasitic cause of chronic diarrhea that mimics IBD and IBS. 1, 2

Additional Useful Tests in This Context

  • Fecal Occult Blood Test (Hemoccult) – Although the patient has visible hematochezia, this serves as baseline documentation. 1, 3

  • C-Reactive Protein (CRP) – While the AGA guidelines suggest against routine CRP for screening, it can help characterize disease activity if IBD is confirmed. 5 However, approximately 20% of patients with active Crohn's disease have normal CRP levels, so a normal result does not exclude IBD. 1 CRP >5 mg/L has been used to distinguish IBD from IBS in multiple studies. 5

Tests You Should NOT Order

  • Do NOT order ESR or CRP alone as screening tests—they have poor diagnostic accuracy for distinguishing IBS from IBD. 2, 4

  • Do NOT order serologic antibody tests for IBS (anti-CdtB, anti-vinculin)—these have only 20-40% sensitivity and are not useful for clinical practice. 2

  • Do NOT order routine ova and parasite testing unless there is specific travel history to endemic areas. 2

  • Do NOT order abdominal ultrasound—it frequently detects incidental findings unrelated to symptoms and does not change management. 1, 4

Why Colonoscopy is Mandatory Here

The combination of hematochezia and weight loss overrides any laboratory testing algorithm. 1, 3 These are absolute alarm features requiring direct visualization and biopsy. 1, 2 The colonoscopy should include:

  • Biopsies from both inflamed and normal-appearing mucosa 1
  • Multiple biopsies to evaluate for microscopic colitis if diarrhea is present 1
  • Terminal ileum intubation if possible to assess for Crohn's disease 1

Clinical Algorithm Summary

  1. Order the mandatory blood panel immediately: CBC, fecal calprotectin, celiac serology (IgA-tTG + total IgA), stool Giardia antigen, fecal occult blood 1, 2

  2. Refer for urgent colonoscopy due to alarm features (hematochezia + weight loss) 1, 3

  3. Do NOT delay endoscopy waiting for laboratory results—the alarm features mandate visualization regardless of blood test results 1, 2

  4. If fecal calprotectin is elevated (>50 mg/g), this strongly supports IBD over functional disease 5, 6

  5. If celiac serology is positive, small bowel biopsy during upper endoscopy confirms diagnosis 5, 1

Common Pitfalls to Avoid

  • Do not diagnose IBS in the presence of alarm features—hematochezia and weight loss exclude functional IBS by definition. 1, 8

  • Do not rely on normal CRP to exclude Crohn's disease—up to 20% of active Crohn's patients have normal inflammatory markers. 1

  • Do not perform extensive serologic testing panels—stick to the evidence-based tests listed above. 2, 8

  • Do not order colonoscopy "if labs are abnormal"—the alarm features present in this case mandate colonoscopy regardless of laboratory results. 1, 3

References

Guideline

Diagnostic Approach to Irritable Bowel Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Evaluation for Irritable Bowel Syndrome with Diarrhea (IBS-D)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Screening for IBS and Digestive Issues: When is Colonoscopy Indicated?

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

[Diagnosis of irritable bowel syndrome: a systematic review].

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Irritable bowel syndrome - an evidence-based approach to diagnosis.

Alimentary pharmacology & therapeutics, 2004

Related Questions

Is a colonoscopy (Colonoscopy) typically normal in patients with Irritable Bowel Syndrome (IBS)?
What laboratory tests should be obtained for a patient presenting with irritable bowel syndrome (IBS)?
What is the role of gastroscopy and colonoscopy in diagnosing irritable bowel syndrome (IBS)?
What are the initial investigations for a patient presenting with symptoms suggestive of irritable bowel syndrome (IBS)?
Can a healthy patient have floating stools for years with no other symptoms and have no cause for concern?
What can be done to manage the increased appetite associated with starting bisoprolol?
What alternative to bisoprolol can be used for blood pressure and heart‑rate control in a patient with post‑ural orthostatic tachycardia syndrome (POTS) and histamine intolerance who is sensitive to many medications and concerned about weight gain?
In a young girl with right lower quadrant pain, afebrile, normal white blood cell count, and mild tenderness, what is the most important management step to avoid missing evolving appendicitis?
I have POTS, histamine intolerance, high medication sensitivity, and am concerned about weight gain; after taking ivabradine I experienced extreme palpitations/heart fluttering—what should I do now?
What is the significance and recommended management of a urine analysis showing moderate ketones (15 mg/dL), trace protein, and trace leukocytes?
Is it safe to start naltrexone while a chlordiazepoxide (Librium) taper is ongoing in a patient with alcohol use disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.